The elevated TLR4 may have a compounding effect on TNF-α-positive osteocytes in CKD mice as levels were 44% higher in oxycodone-treated adenine mice vs. untreated adenine mice, while oxycodone treatment only caused an 11% difference between the non-adenine groups. Here, TLR4 is linked to chronic kidney disease.